References

Oncology

 

Tong Zhang and Charles L. Sentman
Cancer immunotherapy using a bispecific NK receptor fusion protein that engages both T Cells and tumor cells
Cancer Research 2011;71:2066-2076

Tong Zhang, Amorette Barber and Charles L. Sentman
Chimeric NKG2D-modified T Cells inhibit systemic T-Cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways
Cancer Research 2007;67:11029-11036

Laleh Talebian, Jia Yan Wu1,Dawn A. Fischer, John M. Hill1, Zbigniew M. Szczepiorkowski, Marc S. Ernstoff,Charles L. Sentman, and Kenneth R. Meehan 
Novel mobilization strategies to enhance autologous immune effector cells in multiple myeloma
Front Biosci (Elite Ed). 2011 Jun 1;3:1500-8

Charles L. Sentman, PhD, and Kenneth R. Meehan, MD†
NKG2D CARs as Cell Therapy for Cancer
The Cancer Journal 2014 Mar-Apr;20(2):156-9

Amorette Barber, Agnieszka Rynda and Charles L. Sentman
Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment
Journal of Immunology 2009; 183:6939-6947

Tong Zhang, Ming-Ru Wu and Charles L. Sentman
An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo
Journal of Immunology 2012; 189:2290-2299

Paul Spear, Amorette Barber, Agnieszka Rynda-Apple and Charles L. Sentman
Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-g and GM-CSF
Journal of Immunology 2012; 188:6389-6398

Tong Zhang, Ming-Ru Wu and Charles L. Sentman
An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo
Journal of Immunology 2012; 189:2290-2299

Paul Spear, Amorette Barber, Agnieszka Rynda-Apple and Charles L Sentman
NKG2D CAR T-cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors
Immunology and Cell Biology (2013) 00, 1–6 & 2013 Australasian Society for Immunology Inc

Paul Spear, Amorette Barber, Agnieszka Rynda-Apple and Charles L. Sentman
Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-g and GM-CSF
Journal of Immunology 2012; 188:6389-6398

Paul Spear, Amorette Barber, Agnieszka Rynda-Apple, and Charles L. Sentman
NKG2D CAR T cell therapy inhibits the growth of NKG2D ligand heterogenous tumors
Gene Therapy, January 2013

Amorette Barber, Agnieszka Rynda, and Charles L. Sentman
Chimeric NKG2D expressing T cells eliminate immunosuppression and activate immunity within the ovarian tumor microenvironment
Journal of Immunology 2009 December 1; 183(11)

Amorette Barber, Ph.D., Kenneth R. Meehan, M.D., and Charles L. Sentman, Ph.D.
Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
Gene Therapy 2011 May ; 18(5): 509–516

Amorette Barber and Charles L. Sentman
NKG2D receptor regulates human effector T-cell cytokine production
 Blood. 2011 Jun 16;117(24):6571-81

Amorette Barber, Tong Zhang and Charles L. Sentman
Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-Free survival and development of host antitumor immunity in murine ovarian cancer
Journal of Immunology 2008; 180:72-78

Barber A., Rynda A., Sentman CL.
Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment
The Journal of Immunology, 2009 December 1; 183(11): 6939–6947

Zhang T., Barber A., Sentman CL.
Chimeric NKG2D–Modified T Cells Inhibit Systemic T-Cell Lymphoma Growth in a Manner Involving Multiple Cytokines and Cytotoxic Pathways
Cancer Research, 2007, November 15, 67;11029

Barber A., Sentman CL.
NKG2D receptor regulates human effector T-cell cytokine production
Blood, 2011, June 16;117(24):6571-81

Satarupa Basua, Patricia A. Piolib, Jose Conejo-Garciaa, Charles R. Wirab,Charles L. Sentman
Estradiol regulates MICA expression in human endometrial cells
Clinical Immunology (2008) 129, 325–332

Zbigniew Szczepiorkowski, Charles L. Sentman , Marc S. Ernstoff, Kenneth R. Meehan, Laleh Talebian, Tor D. Tosteson, John M. Hill 
Adoptive Cellular Therapy using Cells Enriched for NKG2D+CD3+CD8+T Cells after Autologous Transplantation for Myeloma
Biol Blood Marrow Transplant 19 (2013) 129e137

Amorette Barber, Tong Zhang, Leslie R. DeMars, et al.
Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer
Cancer Res 2007;67:5003-5008.

Melissa A. Barber, Tong Zhang, Bethany A. Gagne and Charles L. Sentman
NK Cells Negatively Regulate Antigen Presentation and Tumor-Specific CTLs in a Syngeneic Lymphoma Model
Journal of Immunology 2007; 178:6140-6147

Amorette Barber, Tong Zhang, Christina J. Megli, Jillian Wu, Kenneth R. Meehan, and Charles L. Sentman
Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma
Exp Hematol. 2008 October ; 36(10): 1318–1328.

Amorette Barber, Tong Zhang and Charles L. Sentman
Immunotherapy with Chimeric NKG2D Receptors Leads to Long-Term Tumor-Free Survival and Development of Host Antitumor Immunity in Murine Ovarian Cancer
Journal of Immunology 2008; 180:72-78;

Cardiology

Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Branko B, Vrolix M, Legrand V, Vrints C, Vanoverschelde J-L, Crespo-Diaz R, Homsy C, Tendera M, Waldman S, Wijns W, Terzic A.    
Cardiopoietic stem cell therapy in heart failure. The C-CURE multicenter randomized trial with lineage-specified biologics.

Journal of the American College of Cardiology 2013.

Murry, C.E., N.J.Palpant and W.R.Maclellan.
Cardiopoietry in motion: primed mesenchymal stem cells for ischemic cardiomyopathy.
J Am Coll Cardiol 2013

Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic  C, Gaussin V, PHD,Homsy C, Bartunek J, Terzic A.
Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction.
J Am Coll Cardiol 2010; 56:721–34.

Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A.
Guided stem cell cardiopoiesis: discovery and translation.
J Mol Cell Cardiol. 2008;45:523-529.

Faustino RS, Behfar A, Perez-Terzic C, Terzic A.
Genomic chart guiding embryonic stem cell cardiopoiesis.
Genome Biol. 2008;9:R6.

Behfar A, Terzic A.
Cardioprotective repair through stem cell-based cardiopoiesis.
J Appl Physiol. 2007;103:1438-1440.

Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederlander N, Alekseev AE, Zingman LV, Terzic A.
Cardiopoietic programming of embryonic stem cells for tumor-free heart repair.
J Exp Med. 2007;204:405-420.

Behfar A, Terzic A.
Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny.
Nat Clin Pract Cardiovasc Med. 2006;3 Suppl 1:S78

Behfar A, Hodgson DM, Zingman LV, Perez-Terzic C, Yamada S, Kane GC, Alekseev AE, Puceat M, Terzic A.
Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair.
Ann N Y Acad Sci. 2005;1049:189-198

Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE, Puceat M, Terzic A.
Stable benefit of embryonic stem cell therapy in myocardial infarction.
Am J Physiol. 2004;287:H471-H479.